APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Neuromodulation Devices and Implantable Infusion Pumps

An implantable infusion pump (IIP) is intended to provide long-term continuous or intermittent drug infusion. Possible routes of administration include intravenous, intra-arterial, subcutaneous, intraperitoneal, intrathecal, epidural, and intraventricular. The IIP is surgically placed in a subcutaneous pocket under the infraclavicular fossa or in the abdominal wall, and a catheter is threaded into the desired position.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

An implantable infusion pump (IIP) is intended to provide long-term continuous or intermittent drug infusion. Possible routes of administration include intravenous, intra-arterial, subcutaneous, intraperitoneal, intrathecal, epidural, and intraventricular. The IIP is surgically placed in a subcutaneous pocket under the infraclavicular fossa or in the abdominal wall, and a catheter is threaded into the desired position.

Selected research

Market Structure

Global Neuromodulation Devices and Implantable Infusion Pumps Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 173916380321 December 2025191 pages

Choose your research edition.

Industry ResearchNeuromodulation Devices and Implantable Infusion Pumps Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Neuromodulation Devices and Implantable Infusion Pumps Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Neuromodulation Devices and Implantable Infusion Pumps Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Neuromodulation Devices and Implantable Infusion Pumps Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Neuromodulation Devices and Implantable Infusion Pumps Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

An implantable infusion pump (IIP) is intended to provide long-term continuous or intermittent drug infusion. Possible routes of administration include intravenous, intra-arterial, subcutaneous, intraperitoneal, intrathecal, epidural, and intraventricular. The IIP is surgically placed in a subcutaneous pocket under the infraclavicular fossa or in the abdominal wall, and a catheter is threaded into the desired position.

In United States, Neuromodulation Devices and Implantable Infusion Pumps key players include Medtronic, Boston Scientific Corporation, St. Jude Medical, etc. Global top three manufacturers hold a share over 75%.

Midwest is the largest market, with a share about 50%, followed by South, and West, both have a share over 45 percent.

Read the full market overview

In terms of product, Spinal Cord Stimulation is the largest segment, with a share over 50%. And in terms of application, the largest application is Pain, followed by Parkinson's disease, Epilepsy, etc.

This report provides an overview of the global Neuromodulation Devices and Implantable Infusion Pumps market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Neuromodulation Devices and Implantable Infusion Pumps and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Neuromodulation Devices and Implantable Infusion Pumps sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Neuromodulation Devices and Implantable Infusion Pumps market size, projected growth trends, production technologies, key applications, and end-use industries.

Neuromodulation Devices and Implantable Infusion Pumps Segment by Company

Medtronic

Boston Scientific Corporation

St. Jude Medical

Synapse Biomedical

Nevro Corporation

Neuropace

Cyberonics

Autonomic Technologies

Avery Biomedical

Greatbatch Medical

Neuromodulation Devices and Implantable Infusion Pumps Segment by Type

Spinal Cord Stimulation

Deep Brain Stimulation

Sacral Nerve Stimulation

Vagal Nerve Stimulation

Gastric Stimulation

Transcranial Magnetic Stimulation

Transcutaneous Electrical Stimulation

Other

Neuromodulation Devices and Implantable Infusion Pumps Segment by Application

Parkinson's Disease

Epilepsy

Pain

Other

Neuromodulation Devices and Implantable Infusion Pumps Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Neuromodulation Devices and Implantable Infusion Pumps market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Neuromodulation Devices and Implantable Infusion Pumps and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Neuromodulation Devices and Implantable Infusion Pumps.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Neuromodulation Devices and Implantable Infusion Pumps market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Neuromodulation Devices and Implantable Infusion Pumps manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Neuromodulation Devices and Implantable Infusion Pumps in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Neuromodulation Devices and Implantable Infusion Pumps in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Neuromodulation Devices and Implantable Infusion Pumps Industry Trends Table 2. Neuromodulation Devices and Implantable Infusion Pumps Industry Drivers Table 3. Neuromodulation Devices and Implantable Infusion Pumps Industry Opportunities and Challenges Table 4. Neuromodulation Devices and Implantable Infusion Pumps Industry Restraints Table 5. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Manufacturers (Unit) & (2021-2026) Table 8. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Manufacturers Table 9. Global Neuromodulation Devices and Implantable Infusion Pumps Average Sales Price (USD/Unit) of Manufacturers (2021-2026) Table 10. Global Neuromodulation Devices and Implantable Infusion Pumps Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Neuromodulation Devices and Implantable Infusion Pumps Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Neuromodulation Devices and Implantable Infusion Pumps Manufacturers, Product Type & Application Table 13. Global Neuromodulation Devices and Implantable Infusion Pumps Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Neuromodulation Devices and Implantable Infusion Pumps by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Spinal Cord Stimulation Table 17. Major Manufacturers of Deep Brain Stimulation Table 18. Major Manufacturers of Sacral Nerve Stimulation Table 19. Major Manufacturers of Vagal Nerve Stimulation Table 20. Major Manufacturers of Gastric Stimulation Table 21. Major Manufacturers of Transcranial Magnetic Stimulation Table 22. Major Manufacturers of Transcutaneous Electrical Stimulation Table 23. Major Manufacturers of Other Table 24. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Type 2021 VS 2025 VS 2032 (Unit) Table 25. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2021-2026) & (Unit) Table 26. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2027-2032) & (Unit) Table 27. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type (2021-2026) Table 28. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type (2027-2032) Table 29. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Type 2021 VS 2025 VS 2032 (Unit) Table 30. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Type (2021-2026) & (Unit) Table 31. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Type (2027-2032) & (Unit) Table 32. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Type (2021-2026) Table 33. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Type (2027-2032) Table 34. Major Manufacturers of Parkinson's Disease Table 35. Major Manufacturers of Epilepsy Table 36. Major Manufacturers of Pain Table 37. Major Manufacturers of Other Table 38. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Application 2021 VS 2025 VS 2032 (Unit) Table 39. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2021-2026) & (Unit) Table 40. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2027-2032) & (Unit) Table 41. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application (2021-2026) Table 42. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application (2027-2032) Table 43. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Application 2021 VS 2025 VS 2032 (Unit) Table 44. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Application (2021-2026) & (Unit) Table 45. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Application (2027-2032) & (Unit) Table 46. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Application (2021-2026) Table 47. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Application (2027-2032) Table 48. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Region: 2021 VS 2025 VS 2032 (Unit) Table 49. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Region (2021-2026) & (Unit) Table 50. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Region (2021-2026) Table 51. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Forecasted by Region (2027-2032) & (Unit) Table 52. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Forecasted Market Share by Region (2027-2032) Table 53. North America Neuromodulation Devices and Implantable Infusion Pumps Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Unit) Table 54. North America Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2021-2026) & (Unit) Table 55. North America Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2027-2032) & (Unit) Table 56. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Unit) Table 57. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2021-2026) & (Unit) Table 58. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2027-2032) & (Unit) Table 59. Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Unit) Table 60. Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2021-2026) & (Unit) Table 61. Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2027-2032) & (Unit) Table 62. South America, Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Unit) Table 63. South America, Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2021-2026) & (Unit) Table 64. South America, Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2027-2032) & (Unit) Table 65. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 66. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Region (2021-2026) & (US$ Million) Table 67. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Region (2027-2032) & (US$ Million) Table 68. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Region (2021-2026) Table 69. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Region (2027-2032) Table 70. Medtronic Company Information Table 71. Medtronic Business Overview Table 72. Medtronic Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Medtronic Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio Table 74. Medtronic Recent Development Table 75. Boston Scientific Corporation Company Information Table 76. Boston Scientific Corporation Business Overview Table 77. Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio Table 79. Boston Scientific Corporation Recent Development Table 80. St. Jude Medical Company Information Table 81. St. Jude Medical Business Overview Table 82. St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio Table 84. St. Jude Medical Recent Development Table 85. Synapse Biomedical Company Information Table 86. Synapse Biomedical Business Overview Table 87. Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio Table 89. Synapse Biomedical Recent Development Table 90. Nevro Corporation Company Information Table 91. Nevro Corporation Business Overview Table 92. Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio Table 94. Nevro Corporation Recent Development Table 95. Neuropace Company Information Table 96. Neuropace Business Overview Table 97. Neuropace Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Neuropace Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio Table 99. Neuropace Recent Development Table 100. Cyberonics Company Information Table 101. Cyberonics Business Overview Table 102. Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio Table 104. Cyberonics Recent Development Table 105. Autonomic Technologies Company Information Table 106. Autonomic Technologies Business Overview Table 107. Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio Table 109. Autonomic Technologies Recent Development Table 110. Avery Biomedical Company Information Table 111. Avery Biomedical Business Overview Table 112. Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio Table 114. Avery Biomedical Recent Development Table 115. Greatbatch Medical Company Information Table 116. Greatbatch Medical Business Overview Table 117. Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 118. Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio Table 119. Greatbatch Medical Recent Development Table 120. Key Raw Materials Table 121. Raw Materials Key Suppliers Table 122. Neuromodulation Devices and Implantable Infusion Pumps Distributors List Table 123. Neuromodulation Devices and Implantable Infusion Pumps Customers List Table 124. Research Programs/Design for This Report Table 125. Authors List of This Report Table 126. Secondary Sources Table 127. Primary Sources List of Figures Figure 1. Neuromodulation Devices and Implantable Infusion Pumps Product Image Figure 2. Global Neuromodulation Devices and Implantable Infusion Pumps Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Neuromodulation Devices and Implantable Infusion Pumps Market Size (2021-2032) & (US$ Million) Figure 4. Global Neuromodulation Devices and Implantable Infusion Pumps Sales (2021-2032) & (Unit) Figure 5. Global Neuromodulation Devices and Implantable Infusion Pumps Average Price (USD/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Neuromodulation Devices and Implantable Infusion Pumps Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Spinal Cord Stimulation Image Figure 9. Deep Brain Stimulation Image Figure 10. Sacral Nerve Stimulation Image Figure 11. Vagal Nerve Stimulation Image Figure 12. Gastric Stimulation Image Figure 13. Transcranial Magnetic Stimulation Image Figure 14. Transcutaneous Electrical Stimulation Image Figure 15. Other Image Figure 16. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2021 VS 2025 VS 2032) & (Unit) Figure 17. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share 2021 VS 2025 VS 2032 Figure 18. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type (2021-2032) Figure 19. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Type (2021 VS 2025 VS 2032) & (Unit) Figure 20. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share 2021 VS 2025 VS 2032 Figure 21. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Type (2021-2032) Figure 22. Parkinson's Disease Image Figure 23. Epilepsy Image Figure 24. Pain Image Figure 25. Other Image Figure 26. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2021 VS 2025 VS 2032) & (Unit) Figure 27. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share 2021 VS 2025 VS 2032 Figure 28. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application (2021-2032) Figure 29. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Application (2021 VS 2025 VS 2032) & (Unit) Figure 30. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share 2021 VS 2025 VS 2032 Figure 31. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Application (2021-2032) Figure 32. North America Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2021-2032) & (Unit) Figure 33. North America Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Country (2021-2032) Figure 34. U.S. Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2021-2032) & (Unit) Figure 35. Canada Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2021-2032) & (Unit) Figure 36. Mexico Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2021-2032) & (Unit) Figure 37. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2021-2032) & (Unit) Figure 38. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Country (2021-2032) Figure 39. Germany Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2021-2032) & (Unit) Figure 40. France Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2021-2032) & (Unit) Figure 41. U.K. Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2021-2032) & (Unit) Figure 42. Italy Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2021-2032) & (Unit) Figure 43. Netherlands Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2021-2032) & (Unit) Figure 44. Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2021-2032) & (Unit) Figure 45. Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Country (2021-2032) Figure 46. China Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2021-2032) & (Unit) Figure 47. Japan Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2021-2032) & (Unit) Figure 48. South Korea Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2021-2032) & (Unit) Figure 49. Southeast Asia Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2021-2032) & (Unit) Figure 50. India Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2021-2032) & (Unit) Figure 51. Australia Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2021-2032) & (Unit) Figure 52. South America, Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2021-2032) & (Unit) Figure 53. South America, Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Country (2021-2032) Figure 54. Brazil Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2021-2032) & (Unit) Figure 55. South Africa Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2021-2032) & (Unit) Figure 56. Saudi Arabia Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2021-2032) & (Unit) Figure 57. Turkey Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2021-2032) & (Unit) Figure 58. Argentina Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2021-2032) & (Unit) Figure 59. UAE Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2021-2032) & (Unit) Figure 60. Egypt Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2021-2032) & (Unit) Figure 61. Chile Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2021-2032) & (Unit) Figure 62. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 63. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 64. North America Neuromodulation Devices and Implantable Infusion Pumps Revenue (2021-2032) & (US$ Million) Figure 65. North America Neuromodulation Devices and Implantable Infusion Pumps Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue (2021-2032) & (US$ Million) Figure 67. Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Revenue (2021-2032) & (US$ Million) Figure 69. Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 70. South America, Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue (2021-2032) & (US$ Million) Figure 71. South America, Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 72. Neuromodulation Devices and Implantable Infusion Pumps Value Chain Figure 73. Manufacturing Cost Structure Figure 74. Neuromodulation Devices and Implantable Infusion Pumps Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • Spinal Cord Stimulation
  • Deep Brain Stimulation
  • Sacral Nerve Stimulation
  • Vagal Nerve Stimulation
  • Gastric Stimulation
  • Transcranial Magnetic Stimulation
  • Transcutaneous Electrical Stimulation
  • Other
Applications
  • Parkinson's Disease
  • Epilepsy
  • Pain
  • Other
Companies covered
  • Medtronic
  • Boston Scientific Corporation
  • St. Jude Medical
  • Synapse Biomedical
  • Nevro Corporation
  • Neuropace
  • Cyberonics
  • Autonomic Technologies
  • Avery Biomedical
  • Greatbatch Medical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Neuromodulation Devices and Implantable Infusion Pumps Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Neuromodulation Devices and Implantable Infusion Pumps Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Neuromodulation Devices and Implantable Infusion Pumps Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Neuromodulation Devices and Implantable Infusion Pumps Market Dynamics
  1. 2.1 Neuromodulation Devices and Implantable Infusion Pumps Industry Trends
  2. 2.2 Neuromodulation Devices and Implantable Infusion Pumps Industry Drivers
  3. 2.3 Neuromodulation Devices and Implantable Infusion Pumps Industry Opportunities and Challenges
  4. 2.4 Neuromodulation Devices and Implantable Infusion Pumps Industry Restraints
3 Neuromodulation Devices and Implantable Infusion Pumps Market by Manufacturers
  1. 3.1 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Manufacturers (2021-2026)
  3. 3.3 Global Neuromodulation Devices and Implantable Infusion Pumps Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Neuromodulation Devices and Implantable Infusion Pumps Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Neuromodulation Devices and Implantable Infusion Pumps Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Neuromodulation Devices and Implantable Infusion Pumps Manufacturers, Product Type & Application
  7. 3.7 Global Neuromodulation Devices and Implantable Infusion Pumps Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Neuromodulation Devices and Implantable Infusion Pumps Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Neuromodulation Devices and Implantable Infusion Pumps Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Neuromodulation Devices and Implantable Infusion Pumps Tier 1, Tier 2, and Tier 3
4 Neuromodulation Devices and Implantable Infusion Pumps Market by Type
  1. 4.1 Neuromodulation Devices and Implantable Infusion Pumps Type Introduction
  2. 4.1.1 Spinal Cord Stimulation
  3. 4.1.2 Deep Brain Stimulation
  4. 4.1.3 Sacral Nerve Stimulation
  5. 4.1.4 Vagal Nerve Stimulation
  6. 4.1.5 Gastric Stimulation
  7. 4.1.6 Transcranial Magnetic Stimulation
  8. 4.1.7 Transcutaneous Electrical Stimulation
  9. 4.1.8 Other
  10. 4.2 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Type
  11. 4.2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2021 VS 2025 VS 2032)
  12. 4.2.2 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2021-2032)
  13. 4.2.3 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type (2021-2032)
  14. 4.3 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Type
  15. 4.3.1 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Type (2021 VS 2025 VS 2032)
  16. 4.3.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Type (2021-2032)
  17. 4.3.3 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Type (2021-2032)
5 Neuromodulation Devices and Implantable Infusion Pumps Market by Application
  1. 5.1 Neuromodulation Devices and Implantable Infusion Pumps Application Introduction
  2. 5.1.1 Parkinson's Disease
  3. 5.1.2 Epilepsy
  4. 5.1.3 Pain
  5. 5.1.4 Other
  6. 5.2 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Application
  7. 5.2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2021-2032)
  9. 5.2.3 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application (2021-2032)
  10. 5.3 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Application
  11. 5.3.1 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Application (2021-2032)
  13. 5.3.3 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Application (2021-2032)
6 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Region
  1. 6.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Region (2021-2032)
  3. 6.2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Region (2021-2026)
  4. 6.2.2 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Neuromodulation Devices and Implantable Infusion Pumps Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Region
  1. 7.1 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Region
  2. 7.1.1 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Region (2021-2026)
  4. 7.1.3 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Region (2027-2032)
  5. 7.1.4 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Neuromodulation Devices and Implantable Infusion Pumps Revenue (2021-2032)
  8. 7.2.2 North America Neuromodulation Devices and Implantable Infusion Pumps Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue (2021-2032)
  11. 7.3.2 Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Medtronic
  2. 8.1.1 Medtronic Company Information
  3. 8.1.2 Medtronic Business Overview
  4. 8.1.3 Medtronic Neuromodulation Devices and Implantable Infusion Pumps Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Medtronic Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio
  6. 8.1.5 Medtronic Recent Developments
  7. 8.2 Boston Scientific Corporation
  8. 8.2.1 Boston Scientific Corporation Company Information
  9. 8.2.2 Boston Scientific Corporation Business Overview
  10. 8.2.3 Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio
  12. 8.2.5 Boston Scientific Corporation Recent Developments
  13. 8.3 St. Jude Medical
  14. 8.3.1 St. Jude Medical Company Information
  15. 8.3.2 St. Jude Medical Business Overview
  16. 8.3.3 St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio
  18. 8.3.5 St. Jude Medical Recent Developments
  19. 8.4 Synapse Biomedical
  20. 8.4.1 Synapse Biomedical Company Information
  21. 8.4.2 Synapse Biomedical Business Overview
  22. 8.4.3 Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio
  24. 8.4.5 Synapse Biomedical Recent Developments
  25. 8.5 Nevro Corporation
  26. 8.5.1 Nevro Corporation Company Information
  27. 8.5.2 Nevro Corporation Business Overview
  28. 8.5.3 Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio
  30. 8.5.5 Nevro Corporation Recent Developments
  31. 8.6 Neuropace
  32. 8.6.1 Neuropace Company Information
  33. 8.6.2 Neuropace Business Overview
  34. 8.6.3 Neuropace Neuromodulation Devices and Implantable Infusion Pumps Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Neuropace Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio
  36. 8.6.5 Neuropace Recent Developments
  37. 8.7 Cyberonics
  38. 8.7.1 Cyberonics Company Information
  39. 8.7.2 Cyberonics Business Overview
  40. 8.7.3 Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio
  42. 8.7.5 Cyberonics Recent Developments
  43. 8.8 Autonomic Technologies
  44. 8.8.1 Autonomic Technologies Company Information
  45. 8.8.2 Autonomic Technologies Business Overview
  46. 8.8.3 Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio
  48. 8.8.5 Autonomic Technologies Recent Developments
  49. 8.9 Avery Biomedical
  50. 8.9.1 Avery Biomedical Company Information
  51. 8.9.2 Avery Biomedical Business Overview
  52. 8.9.3 Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio
  54. 8.9.5 Avery Biomedical Recent Developments
  55. 8.10 Greatbatch Medical
  56. 8.10.1 Greatbatch Medical Company Information
  57. 8.10.2 Greatbatch Medical Business Overview
  58. 8.10.3 Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio
  60. 8.10.5 Greatbatch Medical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Neuromodulation Devices and Implantable Infusion Pumps Value Chain Analysis
  2. 9.1.1 Neuromodulation Devices and Implantable Infusion Pumps Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Neuromodulation Devices and Implantable Infusion Pumps Production Mode & Process
  6. 9.2 Neuromodulation Devices and Implantable Infusion Pumps Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Neuromodulation Devices and Implantable Infusion Pumps Distributors
  9. 9.2.3 Neuromodulation Devices and Implantable Infusion Pumps Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst